Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing NaN - NaN of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cell-free DNA From Junction of Hepatitis B Virus Integration in

Active, not recruiting
  • Hepatocellular Carcinoma
    • Taipei, Taiwan
      National Taiwan University Hospital
    Apr 10, 2023

    Hepatocellular Carcinoma, Biliary Tract Cancer Trial in Worldwide (MEDI5752, Bevacizumab, Lenvatinib)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Biliary Tract Cancer
    • Birmingham, Alabama
    • +44 more
    Mar 17, 2023

    Hepatocellular Carcinoma Trial in Worldwide (Sitravatinib, Tislelizumab, sitravatinib-matching )

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Bengbu, Anhui, China
    • +81 more
    Feb 1, 2023

    Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

    Recruiting
    • Uterine Cervical Neoplasms
    • +10 more
    • Pembrolizumab/Vibostolimab Co-Formulation
    • +11 more
    • Anchorage, Alaska
    • +65 more
    Jan 27, 2023

    Hepatocellular Carcinoma Trial in Worldwide (Nivolumab, Ipilimumab, Sorafenib)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Tucson, Arizona
    • +209 more
    Jan 17, 2023

    Hepatocellular Carcinoma, Advanced Cancer Trial in Charleston, Tainan, Taipei (Sorafenib, CVM-1118)

    Terminated
    • Hepatocellular Carcinoma
    • Advanced Cancer
    • Charleston, South Carolina
    • +2 more
    Jan 6, 2023

    Hepatocellular Carcinoma Trial in Worldwide (drug, other, procedure)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Mobile, Alabama
    • +182 more
    Dec 1, 2022

    Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (Nivolumab, Relatlimab)

    Recruiting
    • Hepatocellular Carcinoma
    • +4 more
    • Nivolumab
    • Relatlimab
    • Ciudad de Buenos Aires, Buenos Aires, Argentina
    • +74 more
    Nov 11, 2022

    Dissection of Molecular and Immunological Interaction in HCC of

    Not yet recruiting
    • Hepatocellular Carcinoma
      • Tainan, Taiwan
      • +2 more
      Nov 6, 2022

      Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

      Recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • +11 more
      • New Haven, Connecticut
      • +12 more
      Nov 3, 2022

      Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma Trial in Taiwan (ADI-PEG20, Placebo)

      Recruiting
      • Hepatocellular Carcinoma
      • Advanced Hepatocellular Carcinoma
      • Changhua, Taiwan
      • +8 more
      Oct 19, 2022

      Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Bevacizumab, Placebo)

      Active, not recruiting
      • Hepatocellular Carcinoma
      • Birmingham, Alabama
      • +213 more
      Aug 19, 2022

      Hepatocellular Carcinoma Trial in Worldwide (Tremelimumab, Durvalumab, Transarterial Chemoembolization (TACE))

      Recruiting
      • Hepatocellular Carcinoma
      • Birmingham, Alabama
      • +132 more
      Jul 20, 2022

      Hepatocellular Carcinoma Trial in Kaohsiung, Tainan, Taipei (T-ACE Oil, Lipiodol)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Kaohsiung, Taiwan
      • +2 more
      Jul 11, 2022

      Hepatocellular Carcinoma Trial in Worldwide (Tremelimumab, Durvalumab, Bevacizumab)

      Active, not recruiting
      Has Results
      • Hepatocellular Carcinoma
      • Tremelimumab
      • +2 more
      • Phoenix, Arizona
      • +43 more
      Jun 22, 2022

      Hepatocellular Carcinoma Trial in New Taipei City, Hualien City, Taipei (ATL administration)

      Recruiting
      • Hepatocellular Carcinoma
      • ATL administration
      • New Taipei City, Taiwan (R. O. C.), Taiwan
      • +3 more
      Jun 10, 2022

      HepatoCellular Carcinoma Trial in Taiwan (Atorvastatin, Placebo Oral Tablet)

      Recruiting
      • HepatoCellular Carcinoma
      • Chiayi City, Taiwan
      • +5 more
      Apr 26, 2022

      Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus

      Terminated
      • Advanced Gastrointestinal (GI) Malignancies
      • +3 more
      • ADI-PEG 20 plus modified FOLFOX6
      • San Francisco, California
      • +34 more
      Apr 18, 2022

      Hepatocellular Carcinoma, Liver Cancer Trial in Singapore, Taiwan, United Kingdom (MTL-CEBPA, Sorafenib 200mg)

      Active, not recruiting
      • Hepatocellular Carcinoma
      • Liver Cancer
      • Singapore, Singapore
      • +10 more
      Apr 4, 2022

      Hepatocellular Carcinoma Trial in Taipei City, Taipei (Para-Toluenesulfonamide)

      Recruiting
      • Hepatocellular Carcinoma
      • Taipei City, Taiwan
      • +2 more
      Mar 28, 2022

      Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Tremelimumab (Regimen 1), Tremelimumab (Regimen 2))

      Recruiting
      • Hepatocellular Carcinoma
      • Los Angeles, California
      • +173 more
      Mar 25, 2022

      Hepatocellular Carcinoma Trial in Worldwide (LY2157299, Sorafenib, Placebo)

      Completed
      Has Results
      • Hepatocellular Carcinoma
      • Beijing, China
      • +15 more
      Feb 14, 2022

      Hepatocellular Carcinoma Trial in Worldwide (Nivolumab, Sorafenib, Ipilimumab)

      Active, not recruiting
      • Hepatocellular Carcinoma
      • Nivolumab
      • +3 more
      • Los Angeles, California
      • +58 more
      Dec 1, 2021

      Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

      Recruiting
      • Liver Fibroses
      • +4 more
      • Observation only
      • Ansan, Korea, Republic of
      • +25 more
      Oct 10, 2021

      Hepatocellular Carcinoma Trial in Worldwide (Cabozantinib tablets, Placebo tablets)

      Completed
      Has Results
      • Hepatocellular Carcinoma
      • Cabozantinib tablets
      • Placebo tablets
      • Corona, California
      • +103 more
      Apr 8, 2021